15074-03-0

Basic information

• Product Name: 3-Oxo-5α-24-cholanoic acid methyl ester
• CAS NO: 15074-03-0
• Molecular Formula: C25H40O3
• Molecular Weight: 388.5833
• Mol File: 15074-03-0.mol
• Article Data: 8

Chemical Properties

• Melting Point: 117-118 °C(Solv: ethyl ether (60-29-7))
• Boiling Point: 471.9±18.0 °C(Predicted)
• Appearance: /
• Density: 1.034±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 3-Oxo-5α-24-cholanoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Oxo-5α-24-cholanoic acid methyl ester(15074-03-0)
• EPA Substance Registry System: 3-Oxo-5α-24-cholanoic acid methyl ester(15074-03-0)

Safety Data

• Hazardous Substances Data: 15074-03-0(Hazardous Substances Data)

Upstream product

• 1184-20-9 methyl 3α,6α-ditosyloxy-5β-cholan-24-oate 
• 2868-48-6 methyl hyodeoxycholate 
• 83-49-8 Hyodeoxycholic Acid 
• 2276-93-9 3β-hydroxy-5α-cholan-24-oic acid 
• 2276-94-0 3α-hydroxy-5α-cholanic acid 
• 73409-98-0 choladiene-1,4 one-3 oate-24 de methyle 
• 1249-75-8 methyl 3β-hydroxy-5α-cholan-24-oate 
• 186581-53-3 diazomethane 
• 19038-19-8 (+)-3-oxo-5α-cholan-24-oic acid 
• 20231-57-6 methyl 5-cholenoate 
• 1452-33-1 methyl 3-oxo-4-cholenolate 

Relevant articles and documents

OXYSTEROLS AND METHODS OF USE THEREOF

Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R2, R3, R4, R5, and and R6 are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, wherein Z is a group of the formula (i), (ii), (iii), (iv), or (v), and wherein L1, L2, L3, X1, X2, Y, Rz4, Rz5, Rz6, n, R1, R2, R3a, R3b, R4a, R4b, R6a, R6b, R7a, R7b, R11a, R11b, R14, R17, R19, R20, R23a, R23b, and R24 are as defined herein, and pharmaceutical compositions thereof. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions in mammals.

Method of treating a viral infection by administering a steroid compound

A method of treating a viral infection includes administering an effective amount of a compound having the following structure: STR1 or a pharmaceutically acceptable salt thereof. This compound treats the viral infection by suppressing the growth of a viral target cell. As one specific example, this compound may be used to treat HIV infection.